ATE317435T1 - Prostataspezifisches membranes antigen und seine anwendungen - Google Patents
Prostataspezifisches membranes antigen und seine anwendungenInfo
- Publication number
- ATE317435T1 ATE317435T1 AT96908504T AT96908504T ATE317435T1 AT E317435 T1 ATE317435 T1 AT E317435T1 AT 96908504 T AT96908504 T AT 96908504T AT 96908504 T AT96908504 T AT 96908504T AT E317435 T1 ATE317435 T1 AT E317435T1
- Authority
- AT
- Austria
- Prior art keywords
- specific membrane
- applications
- provides
- membrane antigen
- prostate specific
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/394,152 US5935818A (en) | 1995-02-24 | 1995-02-24 | Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof |
| US08/470,735 US7105159B1 (en) | 1992-11-05 | 1995-06-06 | Antibodies to prostate-specific membrane antigen |
| US08/466,381 US6953668B1 (en) | 1992-11-05 | 1995-06-06 | Prostate-specific membrane antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE317435T1 true ATE317435T1 (de) | 2006-02-15 |
Family
ID=27410106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96908504T ATE317435T1 (de) | 1995-02-24 | 1996-02-23 | Prostataspezifisches membranes antigen und seine anwendungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7037647B1 (de) |
| EP (2) | EP1754788A3 (de) |
| JP (4) | JP2001526522A (de) |
| AT (1) | ATE317435T1 (de) |
| AU (1) | AU717937B2 (de) |
| CA (1) | CA2212846A1 (de) |
| DE (1) | DE69635801T2 (de) |
| MX (1) | MX9706311A (de) |
| WO (1) | WO1996026272A1 (de) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7070782B1 (en) | 1992-11-05 | 2006-07-04 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| US6953668B1 (en) | 1992-11-05 | 2005-10-11 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| US7105159B1 (en) | 1992-11-05 | 2006-09-12 | Sloan-Kettering Institute For Cancer Research | Antibodies to prostate-specific membrane antigen |
| US6103237A (en) * | 1993-07-22 | 2000-08-15 | Hybritech Incorporated | Stable variant hK2 polypeptide |
| US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| AU699748B2 (en) * | 1994-05-10 | 1998-12-10 | Hybritech Incorporated | Recombinant HK2 polypeptide |
| US20040253246A1 (en) * | 1996-02-23 | 2004-12-16 | Israeli Ron S. | Prostate-specific membrane antigen and uses thereof |
| FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
| US6881571B1 (en) | 1998-03-11 | 2005-04-19 | Exonhit Therapeutics S.A. | Qualitative differential screening |
| US6962981B1 (en) | 1996-03-25 | 2005-11-08 | Medarex, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| US7381407B1 (en) | 1996-03-25 | 2008-06-03 | Medarex, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| IL126314A (en) * | 1996-03-25 | 2003-07-31 | Northwest Biotherapeutics Inc | Monoclonal antibodies having an antigen binding region specific for the extracellular domain of prostate specific membrane antigen (psma) |
| US6107090A (en) | 1996-05-06 | 2000-08-22 | Cornell Research Foundation, Inc. | Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains |
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| US5795877A (en) * | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US5804602A (en) * | 1996-06-17 | 1998-09-08 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| US5672592A (en) * | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| US6046180A (en) * | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US6384022B1 (en) | 1996-06-17 | 2002-05-07 | Guilford Pharmaceuticals Inc. | Prodrugs of NAALAdase inhibitors |
| US5902817A (en) * | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
| US5863536A (en) * | 1996-12-31 | 1999-01-26 | Guilford Pharmaceuticals Inc. | Phosphoramidate derivatives |
| US6054444A (en) | 1997-04-24 | 2000-04-25 | Guilford Pharmaceuticals Inc. | Phosphonic acid derivatives |
| US6071965A (en) * | 1996-06-17 | 2000-06-06 | Guilford Pharmaceuticals Inc. | Phosphinic alkanoic acid derivatives |
| US6025344A (en) * | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
| JP2001503991A (ja) * | 1996-11-14 | 2001-03-27 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | 転移性前立腺癌の検出方法 |
| US6479263B1 (en) | 1996-11-14 | 2002-11-12 | Baylor College Of Medicine | Method for detection of micrometastatic prostate cancer |
| WO1998059073A1 (en) | 1997-06-20 | 1998-12-30 | Mayo Foundation For Medical Education And Research | Method for detection of breast cancer |
| US6028216A (en) * | 1997-12-31 | 2000-02-22 | Guilford Pharmaceuticals Inc. | Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives |
| WO1999043710A1 (en) * | 1998-02-26 | 1999-09-02 | Beckman Coulter, Inc. | Prostate-specific membrane antigens and methods of making and using |
| US6395718B1 (en) | 1998-07-06 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors |
| CN1314882A (zh) | 1998-07-06 | 2001-09-26 | 吉尔福德药物有限公司 | 用作药物化合物的naalad酶抑制剂和组合物 |
| US6265609B1 (en) | 1998-07-06 | 2001-07-24 | Guilford Pharmaceuticals Inc. | Thio-substituted pentanedioic acid derivatives |
| AU5815699A (en) * | 1998-09-08 | 2000-03-27 | Urocor, Inc. | Prostate specific promoter and regulation of gene expression |
| US6444657B1 (en) | 1998-12-31 | 2002-09-03 | Guilford Pharmaceuticals Inc. | Methods for treating certain diseases using naaladase inhibitors |
| JP4495349B2 (ja) | 1999-01-28 | 2010-07-07 | ジェン−プローブ・インコーポレーテッド | 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列 |
| WO2000050457A1 (en) * | 1999-02-22 | 2000-08-31 | Beckman Coulter, Inc. | Prostate-specific membrane antigens and methods of making and using |
| CA2364492C (en) * | 1999-03-01 | 2014-08-19 | Commonwealth Scientific And Industrial Research Organisation | Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| AU774697B2 (en) * | 1999-04-09 | 2004-07-01 | Sloan-Kettering Institute For Cancer Research | DNA encoding the prostate-specific membrane antigen-like gene and uses thereof |
| US6313159B1 (en) | 1999-08-20 | 2001-11-06 | Guilford Pharmaceuticals Inc. | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
| EP1392360B1 (de) | 2001-06-01 | 2011-11-30 | Cornell Research Foundation, Inc. | Modifizierte antikörper gegen prostata-spezifisches membranantigen und ihre verwendungen |
| IL159422A0 (en) | 2001-09-20 | 2004-06-01 | Cornell Res Foundation Inc | Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen |
| AU2002356844C1 (en) | 2001-10-23 | 2010-03-04 | Amgen Fremont Inc. | PSMA antibodies and protein multimers |
| US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
| GR20020100189A (el) * | 2002-04-17 | 2003-12-22 | Zeincro Ελλας Ανωνυμη Εταιρεια Συμβουλων Φαρμακευτικων Επιχειρησεων | Προφαρμακα αντιγονων ειδικων της προστατικης μεμβρανης |
| ES2314272T3 (es) | 2003-01-10 | 2009-03-16 | Millennium Pharmaceuticals, Inc. | Metodos para el diagnostico y el tratamiento del cancer. |
| MX2007009935A (es) | 2005-02-18 | 2007-10-10 | Medarex Inc | Anticuerpos monoclonales que carecen de residuos fucosilo contra antigeno membranal especifico de prostata (psma). |
| US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| EP1996716B1 (de) | 2006-03-20 | 2011-05-11 | The Regents of the University of California | Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting |
| EP2589668A1 (de) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten |
| US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
| US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
| US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
| JP6126773B2 (ja) | 2007-09-04 | 2017-05-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌のターゲッティングおよび検出のための高親和性抗前立腺幹細胞抗原（ｐｓｃａ）抗体 |
| KR101345288B1 (ko) * | 2007-09-21 | 2013-12-27 | 삼성전자주식회사 | 2축 구동 전자기 스캐너 |
| EP2205249B1 (de) | 2007-09-28 | 2018-11-07 | Intrexon Corporation | Therapeutische genschalterkonstrukte und bioreaktoren zur expression biotherapeutischer moleküle und ihre verwendung |
| EP2209498A2 (de) * | 2007-10-03 | 2010-07-28 | Cornell University | Behandlung von proliferativen erkrankungen mit psma-antikörpern |
| EP2727606A3 (de) | 2008-09-08 | 2015-09-23 | Psma Development Company, L.L.C. | Verbindungen zur tötung von psma-expriemierenden und taxane-resistenten krebszellen |
| SI2334812T1 (sl) | 2008-09-20 | 2017-05-31 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 | Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem |
| WO2010096486A1 (en) | 2009-02-17 | 2010-08-26 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| CA2782333C (en) | 2009-12-02 | 2019-06-04 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| NZ739721A (en) | 2015-08-07 | 2019-09-27 | Imaginab Inc | Antigen binding constructs to target molecules |
| EP3579870A4 (de) | 2017-02-07 | 2020-12-30 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | Auf car-t-zell-tumor (ctct) abzielende phospholipidether (ple)-wirkstoffe |
| WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
| US11850262B2 (en) | 2017-02-28 | 2023-12-26 | Purdue Research Foundation | Compositions and methods for CAR T cell therapy |
| TW201940182A (zh) | 2018-01-22 | 2019-10-16 | 美商安德賽特公司 | Car t 細胞之使用方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| DE3432714A1 (de) | 1984-09-06 | 1986-04-24 | Behringwerke Ag, 3550 Marburg | Tumortherapeutikum und verfahren zu seiner herstellung |
| US5162504A (en) | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| US5674682A (en) | 1992-10-29 | 1997-10-07 | Thomas Jefferson University | Nucleic acid primers for detecting micrometastasis of prostate cancer |
| EP1757694A3 (de) * | 1992-11-05 | 2008-02-27 | Sloan Kettering Institute For Cancer Research | Prostata-spezifisches Membranantigen |
| US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| US5935818A (en) | 1995-02-24 | 1999-08-10 | Sloan-Kettering Institute For Cancer Research | Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof |
| US6011021A (en) | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| US5773292A (en) | 1995-06-05 | 1998-06-30 | Cornell University | Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood |
| IL126314A (en) | 1996-03-25 | 2003-07-31 | Northwest Biotherapeutics Inc | Monoclonal antibodies having an antigen binding region specific for the extracellular domain of prostate specific membrane antigen (psma) |
| US6150508A (en) | 1996-03-25 | 2000-11-21 | Northwest Biotherapeutics, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| US6962981B1 (en) | 1996-03-25 | 2005-11-08 | Medarex, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| US6107090A (en) | 1996-05-06 | 2000-08-22 | Cornell Research Foundation, Inc. | Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains |
| US5795877A (en) | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US5804602A (en) | 1996-06-17 | 1998-09-08 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| RU2218179C2 (ru) | 1996-06-17 | 2003-12-10 | Гилфорд Фармасьютикалз Инк. | СПОСОБЫ ЛЕЧЕНИЯ РАКА С ПРИМЕНЕНИЕМ ИНГИБИТОРОВ NAALADазы |
| US5672592A (en) | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| US6384022B1 (en) | 1996-06-17 | 2002-05-07 | Guilford Pharmaceuticals Inc. | Prodrugs of NAALAdase inhibitors |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5863536A (en) | 1996-12-31 | 1999-01-26 | Guilford Pharmaceuticals Inc. | Phosphoramidate derivatives |
| US6025344A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| US6054444A (en) | 1997-04-24 | 2000-04-25 | Guilford Pharmaceuticals Inc. | Phosphonic acid derivatives |
| US6025345A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US6046180A (en) | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US5902817A (en) | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
| KR20000036227A (ko) | 1996-09-27 | 2000-06-26 | 토마스 씨. 서 | 날라다아제조성물, 글루탐산염 이상 치료법 및 동물내의 뉴우런활성법 |
| US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
| US5981209A (en) | 1997-12-04 | 1999-11-09 | Guilford Pharmaceuticals Inc. | Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia |
| US6121252A (en) | 1998-03-30 | 2000-09-19 | Guilford Pharmaceuticals Inc. | Phosphinic acid derivatives |
| US6395718B1 (en) | 1998-07-06 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors |
| CN1314882A (zh) | 1998-07-06 | 2001-09-26 | 吉尔福德药物有限公司 | 用作药物化合物的naalad酶抑制剂和组合物 |
| US6444657B1 (en) | 1998-12-31 | 2002-09-03 | Guilford Pharmaceuticals Inc. | Methods for treating certain diseases using naaladase inhibitors |
| US6348464B1 (en) | 1999-11-12 | 2002-02-19 | Guilford Pharmaceuticals, Inc. | Pyrrolecarbonylimino derivatives as naaladase inhibitors |
| WO2001091738A2 (en) | 2000-05-30 | 2001-12-06 | Guilford Pharmaceuticals Inc. | Naaladase inhibitors for treating amyotrophic lateral sclerosis |
| AU2001265111A1 (en) | 2000-05-30 | 2001-12-11 | Guilford Pharmaceuticals Inc. | Benzenedicarboxylic acid derivatives |
| EP1202440B1 (de) | 2000-10-17 | 2006-12-20 | Omron Corporation | Dämpferschaltung und Leistungswandler der diese anwendet |
| EP1353903A2 (de) | 2001-01-17 | 2003-10-22 | Guilford Pharmaceuticals Inc. | Thiolverbindungen als naaladase inhibitoren |
| US20030007974A1 (en) | 2001-05-30 | 2003-01-09 | Nanus David M. | Endopeptidase/anti-PSMA antibody fusion proteins for treatment of cancer |
-
1996
- 1996-02-23 DE DE69635801T patent/DE69635801T2/de not_active Expired - Lifetime
- 1996-02-23 AU AU51725/96A patent/AU717937B2/en not_active Ceased
- 1996-02-23 EP EP06002339A patent/EP1754788A3/de not_active Withdrawn
- 1996-02-23 EP EP96908504A patent/EP0812356B1/de not_active Expired - Lifetime
- 1996-02-23 JP JP52582196A patent/JP2001526522A/ja not_active Withdrawn
- 1996-02-23 CA CA002212846A patent/CA2212846A1/en not_active Abandoned
- 1996-02-23 US US08/894,583 patent/US7037647B1/en not_active Expired - Fee Related
- 1996-02-23 WO PCT/US1996/002424 patent/WO1996026272A1/en active Search and Examination
- 1996-02-23 AT AT96908504T patent/ATE317435T1/de not_active IP Right Cessation
-
1997
- 1997-08-19 MX MX9706311A patent/MX9706311A/es not_active IP Right Cessation
-
2004
- 2004-09-02 JP JP2004256270A patent/JP2005036008A/ja not_active Withdrawn
- 2004-09-02 JP JP2004256273A patent/JP2005052145A/ja not_active Withdrawn
- 2004-09-02 JP JP2004256265A patent/JP2005185276A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US7037647B1 (en) | 2006-05-02 |
| DE69635801T2 (de) | 2006-11-02 |
| JP2005185276A (ja) | 2005-07-14 |
| EP1754788A3 (de) | 2007-04-25 |
| CA2212846A1 (en) | 1996-08-29 |
| JP2001526522A (ja) | 2001-12-18 |
| JP2005052145A (ja) | 2005-03-03 |
| AU5172596A (en) | 1996-09-11 |
| EP0812356A4 (de) | 2002-04-03 |
| JP2005036008A (ja) | 2005-02-10 |
| EP0812356A1 (de) | 1997-12-17 |
| MX9706311A (es) | 1998-06-30 |
| DE69635801D1 (de) | 2006-04-20 |
| EP1754788A2 (de) | 2007-02-21 |
| EP0812356B1 (de) | 2006-02-08 |
| AU717937B2 (en) | 2000-04-06 |
| WO1996026272A1 (en) | 1996-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE317435T1 (de) | Prostataspezifisches membranes antigen und seine anwendungen | |
| BR9710968A (pt) | Antìgenos de célula b humana; reagentes correlatos | |
| AU7019498A (en) | Pca3, pca3 genes, and methods of use | |
| BR9811039A (pt) | Citocina de mamìferos: interleucina-b30 e reagentes relacionados | |
| AU4055697A (en) | Mammalian cell surface antigens; related reagents | |
| ATE549347T1 (de) | Gene von säugetiere, und damit verbundene reagentien, methoden | |
| CY1111006T1 (el) | Εκριμματαση ασθενειας alzheimer | |
| FI961251A (fi) | Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet | |
| DE69623458T2 (de) | Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung | |
| TR199701462T1 (xx) | DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini. | |
| HK1090422A1 (en) | A system for determining the electrical potential across a membrane | |
| ATE529509T1 (de) | Selektion von proteinen unter verwendung von rna- protein-fusionen | |
| DE69739465D1 (de) | Methoden zur Analyse von Nukleinsäure-Molekülen mittels Techniken zur Grössen-bestimmung | |
| DK1114864T4 (da) | Pattedyrcelleoverfladeantigener samt tilhørende reagenser | |
| DE69739751D1 (de) | Isolierte gene aus säuger monozyten und betreffende reagentien | |
| ES2121358T3 (es) | Anticuerpos monoclonales humanizados contra interleuquina-4 humana. | |
| DE69728897D1 (de) | Saeugetierchemokine | |
| ATE294237T1 (de) | S?ugetier thymokingene | |
| BR9713632A (pt) | Citocina de mamìfero relacionada com a il-10 | |
| WO1999047673A3 (en) | Isolated mammalian membrane protein genes and related reagents | |
| AR016145A1 (es) | Citoquinas de mamifero; reactivos relacionados | |
| ECSP982583A (es) | Genes aislados de proteinas de membranas de mamiferos reactivos relacionados | |
| DE60023695D1 (de) | Tumorsuppressormoleküle und nutzungsverfahren | |
| MX9703956A (es) | Genes purificados que codifican antigenos de superficie de celulas de mamiferos; proteinas y anticuerpos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |